AbbVie Inc
(LTS:0QCV)
$
202.39
0.335 (0.17%)
Market Cap: 352.54 Bil
Enterprise Value: 416.34 Bil
PE Ratio: 69.27
PB Ratio: 58.44
GF Score: 87/100 Abbvie Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024 / 04:15PM GMT
Release Date Price:
$162.8
(+0.46%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting a fireside chat today with AbbVie. From the company, we have Rob Michael, President and Chief Operating Officer; Jeff Stewart, Chief Commercial Officer; Scott Reents, CFO; and Roopal Thakkar, Chief Medical Officer. So thanks, everyone, for joining us today.
Robert A. Michael
AbbVie Inc. - President & COO
Thanks for having us Chris.
Questions & Answers
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
So Rob, maybe just to kick off, looking at 2024, can you just walk through some of your top priorities and there's been a lot of activity with the company. So how this might change over the course of the last year or so?
Robert A. Michael
AbbVie Inc. - President & COO
The focus for the company is clearly on trying to return to growth in '25, like
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot